Factor VIII/von Willebrand factor (Bio Products Laboratory)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFactor VIII/von Willebrand factor (Bio Products Laboratory)

Drug Alias NameFVIII/VWF凝血因子 VIII/假性血友病因子 - Bio Products LaboratoryFactor VIII/VWF凝血因子VIII/血管性血友病因子 - Bio Products LaboratoryOptivate

ClassificationBiologics > Blood components

Mechanisms of ActionCoagulation factor VIII replacementsCoagulation factor X stimulantsVon willebrand factor replacements +[4]

TargetsCoagulation factor VIIICoagulation factor X

Therapy Area/Indicationsvon Willebrand DiseasesHemophilia A

Global Approved IndicationsHemophilia A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved Date2004/12/01

Country/TerritoryPolandUnited KingdomIsrael

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive Indicationsvon Willebrand Diseases

ATC CodeB02BD06